Aurobindo Pharma consolidated net profit declines 0.58% in the March 2025 quarter

Net profit of Aurobindo Pharma declined 0.58% to Rs 903.47 crore in the quarter ended March 2025 as against Rs 908.75 crore during the previous quarter ended March 2024. Sales rose 11.87% to Rs 8381.12 crore in the quarter ended March 2025 as against Rs 7491.92 crore during the previous quarter ended March 2024.

For the full year,net profit rose 9.86% to Rs 3485.88 crore in the year ended March 2025 as against Rs 3172.97 crore during the previous year ended March 2024. Sales rose 9.31% to Rs 31378.13 crore in the year ended March 2025 as against Rs 28704.50 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	8381.12	7491.92	12	31378.13	28704.50	9
OPM %	21.00	22.16	-	20.88	20.30	-
PBDT	1779.52	1706.34	4	6715.71	6093.51	10
PBT	1335.09	1352.01	-1	5066.29	4571.85	11
NP	903.47	908.75	-1	3485.88	3172.97	10